Search results
Showing 6511 to 6525 of 7707 results
Cox-II inhibitors for the treatment of osteoarthritis and rheumatoid arthritis [ID388]
Discontinued [GID-TAG372]
Tanezumab for treating moderate to severe chronic pain caused by osteoarthritis [ID1603]
Discontinued [GID-TA10711]
Reducing the mortality and morbidity for healthcare associated infections
Discontinued [GID-NG10059]
Lorcaserin hydrochloride for the treatment of obesity and overweight [ID337]
Discontinued [GID-TAG420]
Masitinib for treating amyotrophic lateral sclerosis [ID967]
Discontinued [GID-TA10157]
Quizartinib for treating relapsed or refractory acute myeloid leukaemia [ID1325]
Discontinued [GID-TA10363]
Lymphoma (non Hodgkin's, peripheral T-cell) - pralatrexate [ID368]
Discontinued [GID-TAG424]
Leukaemia (acute myeloid, relapsed, refractory) - vosaroxin [ID746]
Discontinued [GID-TA10070]
Moxetumomab pasudotox for treating hairy-cell leukaemia [ID1142]
Discontinued [GID-TA10923]
Discontinued [GID-TAG421]
PredictSure-IBD for inflammatory bowel disease prognosis (MIB178)
This medtech innovation briefing has been updated and replaced by NICE medtech innovation briefing 313.
UroShield for preventing catheter-associated urinary tract infections (MIB191)
This advice has been updated and replaced by NICE medical technologies guidance 69.
This advice has been updated and replaced by NICE medical technologies guidance 56.
DyeVert for reducing contrast media in coronary and peripheral angiography (MIB196)
This advice has been updated and replaced by NICE medical technologies guidance 60.